• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 3
  • Tagged with
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
1

Development of a Microemulsion High Performance Liquid Chromatography (MELC) Method for Determination of Salbutamol in Metered-Dose Inhalers (MDIS)

Althanyan, Mohammed S., Clark, Brian J., Hanaee, Jalal, Assi, Khaled H. January 2013 (has links)
No / A sensitive and rapid oil-in-water (O/W) microemulsion high performance liquid chromatography (MELC) method has been developed. The water-in-oil (w/o) microemulsion was used as a mobile phase in the determination of salbutamol in aqueous solutions. In addition, the influence of operating parameters on the separation performance was examined. The samples were injected into C18, (250mmx4.6mm) analytical columns maintained at 25(o)C with a flow rate 1 ml/min. The mobile phase was 95.5% v/v aqueous orthophosphate buffer 20 mM (adjusted to pH 3 with orthophosphoric acid), 0.5% ethyl acetate, 1.5% Brij35, and 2.5% 1-butanol, all w/w. The salbutamol and internal standard peaks were detected by fluorescence detection at the excitation and emission wavelengths of 267 and 313 nm respectively. The method had an accuracy of > 97.78% and the calibration curve was linear (r2 = 0.99) over salbutamol concentrations ranging from 25 to 500 ng/mL. The intra-day and inter-day precisions (CV %) were <1.6 and <1.8, respectively. The limit of detection (LOD) and limit of quantitation (LOQ) were 9.61ng/ml and 29.13ng/ml, respectively. The method reported is simple, precise and accurate, and has the capacity to be used for determination of salbutamol in the pharmaceutical preparation.
2

Microemulsion High Performance Liquid Chromatography (MELC) for Determination of Terbutaline in Urine Samples

Althanyan, Mohammed S., Nasser, A., Assi, H., Clark, Brian J., Assi, Khaled H. 10 October 2015 (has links)
No / An isocratic oil-in-water microemulsion High Performance Liquid Chromatography (MELC) was developed and validated for the determination of terbutaline in urine samples. A solid phase extraction (SPE) method which used Oasis HLB cartridges was optimised to isolate terbutaline from a urine matrix followed by HPLC with fluorescence detection. The urinary assay was performed in accordance with FDA and ICH regulations for the validation of bioanalytical samples. The method uses the isocratic oil-in-water micro emulsion to separate the terbutaline from the endogenous urine components. The chromatographic separation was carried out on C18-Spherisorb (250mm×4.6mm) analytical column maintained at 30 °C. The mobile phase was 94.4% aqueous orthophosphate buffer (adjusted to pH 3 with orthophosphoric acid), 0.5% ethyl acetate, 1.5% Brij35, 2.5% 1-butanol and 1.1% Octanesulfonic acid (OSA), all w/w. The terbutaline peak was detected by fluorescence detection, using excitation and emission wavelengths of 267 and 313 nm, respectively. The linearity of response was demonstrated at six different concentrations of terbutaline which were extracted from spiked urine, ranging from 60 to 1000ng/ml. The terbutaline was extracted from urine by a solid phase extraction clean-up procedure on Oasis HLB cartridges, and the relative recovery was >87.64% (n = 5). The limit of detection (LOD) and limit of quantitation (LOQ) in urine were 20.21 and 61.24ng/ml, respectively. The intra-day and inter-day precisions (in term of % coefficient of variation) were <3.56% and <2.87%, respectively. In the method development the influence of the composition of the microemulsion system was also studied and the method was found to be robust with respect to changes of the microemulsion components.
3

Identification of human peripheral blood monocyte derived pro-inflammatory dendritic cells

Toschka, Robert 02 December 2014 (has links)
Dendritische Zellen (DZ) sind essentiell für die Aktivierung von Immunantworten. Drei Flt3-abhängige DZ Populationen aus dem Blut bestehend aus konventionellen (kDZ) BDCA1+ DZs und BDCA3+ DZs und plasmazytoide DZs wurden bereits beschrieben. Hier wurden zum ersten Mal sich aus Monozyten entwickelnde DZ (moDZ), genauer BDCA1+CD14+ pro-inflammatorische DZ (pro-iDZ) aus periphärem Blut unter homöostatischen Bedingungen identifiziert. Isolierte pro-iDZ sekretierten spontan große Mengen an pro-inflammatorischen Zytokinen, die kDZ reifen ließen und T Zell Proliferation unterstützten. Sie waren BDCA1+CD14- DZ und CD14+CD16- Monozyten in der TH17 Zell Induktion überlegen. Pro-iDZ ähnliche BDCA1+CD14+ Zellen konnten durch imaging cycler microscopy in Geweben von Patienten die an Psoriasis, Dermatomyositis oder entzündetem Halonävus erkrankt waren identifiziert werden. Ihr Fehlen in gesunder Haut deutete eine Rekrutierung von pro-iDZs in entzündetes Gewebe an. Eine Verwandtschaftsanalyse von pro-iDZ zwischen Monozyten, kDZ des Blutes und in vitro generierten moDZ auf genomweiter Ebene wies auf einen monozytären Ursprung hin. Anylse mittels funktioneller Annotation auf differentiell exprimierten Genen zwischen pro-iDZ und Monozyten zeigte eine DZ spezifische Gensignatur auf. Diese Gene waren insgesamt in der gleichen Weise wie in kDZ und moDZ reguliert, das eine Entwicklung von Monozyten nach DZ nahelegte. Dieses Entwicklungskonzept wurde insofern unterstützt, indem unter entzündlichen Bedingungen kultivierte CD14+CD16- Monozyten BDCA1 Expression und DZ Funktion erlangten. Da pro-iDZ sehr ähnlich zu BDCA1+CD14+ Zellen aus entzündeter Haut waren und beide große Konvergenz mit zuvor beschriebenen BDCA1+CD14+ inflammatorischen DZ (infDZ) aus entzündeten Geweben aufwiesen, können pro-iDZ als direkte infDZ Vorläufer angesehen werden. Dadurch und wegen ihrer monozytären Herkunft können pro-iDZ als Beweis für die humane Differenzierung von Monozyten nach DZ in vivo betrachtet werden. / Dendritic cells (DCs) are critical for the activation of immune responses. Three Flt3-dependent blood DC populations including conventional BDCA1+ DCs and BDCA3+ DCs (cDCs) and plasmacytoid DCs were described previously. This work identifies for the first time human peripheral blood monocyte derived BDCA1+CD14+ pro-inflammatory DCs (pro-iDCs) during steady state. Isolated pro-iDCs spontaneously secreted high amounts of pro-inflammatory cytokines, which matured cDCs and promoted T cell proliferation. They were superior in priming TH17 cells when compared to BDCA1+CD14- DCs and CD14+CD16- monocytes. BDCA1+CD14+ cells resembling blood pro-iDCs as identified by imaging cycler microscopy were found in samples from patients suffering from psoriasis, dermatomyositosis and inflamed halo nevus. Their absence in healthy donor’s skin indicated a recruitment of pro-iDCs to sites of inflammation. Analysis of the developmental relationship of pro-iDCs between monocytes, blood cDCs and in vitro generated monocyte derived DCs (moDCs) on whole genome level strongly suggested a monocytic origin. Functional annotation analysis of differentially regulated genes between monocytes and pro-iDCs revealed a DC specific gene signature. In addition, these genes were overall regulated in the same way in blood cDCs and moDCs, indicating an ongoing development of pro-iDCs from monocytes towards DCs. This developmental concept was supported as CD14+CD16- monocytes cultured under inflammatory conditions gained BDCA1 expression and DC function. Since pro-iDCs were highly similar to BDCA1+CD14+ cells found in inflamed skin and as both showed a marked convergence with BDCA1+CD14+ inflammatory DCs (infDCs) present in inflamed tissues described previously, pro-iDCs can be regarded as immediate precursors of infDCs. Thus, in respect of a monocytic origin and a presumably inflammatory DC fate, pro-iDCs may constitute a missing link to prove human moDC differentiation in vivo.

Page generated in 0.0196 seconds